Hypertension Treatment in Patients with Metabolic Syndrome and/or Type 2 Diabetes Mellitus: Analysis of the Therapy Effectivity and the Therapeutic Inertia in Outpatient Study

Table 3

Combination of three drugs: effect on BP values.

	Number of patients	Start		End		Average decrease of sBP	Average decrease of dBP
		Average sBP	Average dBP	Average sBP	Average dBP
Telmisartan	21	175	90	141	75	34	15
Hydrochlorothiazide
Urapidil
Hydrochlorothiazide	3	155	81	145	69	10	12
Urapidil
Irbesartan
Nitrendipine	44	170	90	136	74	34	15
Telmisartan
Hydrochlorothiazide
Spironolactone	9	179	86	139	70	41	16
Telmisartan
Hydrochlorothiazide